文献速递神经肿瘤

CRISPR/Cas9介导的CD95L/CD95信号消除可抑制胶质瘤细胞生长与免疫抑制并提高小鼠胶质瘤模型生存率

CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.
PubMed 文献 · J Neurooncol · 2022-11-10

研究利用CRISPR/Cas9在小鼠胶质瘤模型中敲除Cd95或Cd95l基因,体外发现基因删除降低细胞生长,体内Cd95或Cd95l基因删除通过肿瘤内在和免疫机制延长SMA-497模型生存,在无CD95表达的GL-261模型中仅CD95L基因删除通过肿瘤内在机制延长生存。

要点

  • 小鼠胶质瘤细胞体外表达经典CD95但不表达CD95L,检测到可溶性非经典Cd95l转录变体。
  • Cd95或Cd95l基因删除降低体外细胞生长,Cd95回补转染可恢复生长。
  • SMA-497模型中Cd95或Cd95l删除延长生存涉及肿瘤内在和免疫机制;GL-261模型仅CD95L删除延长生存涉及肿瘤内在机制。

核心结论

  • 非经典CD95L/CD95相互作用在小鼠胶质瘤模型中促进生长,Cd95l基因沉默可能同时拮抗胶质瘤生长和免疫抑制。

研究设计与样本

  • 在小鼠胶质瘤模型中用CRISPR/Cas9敲除组成型Cd95和Cd95l基因表达,并在体外和体内表征基因删除的后果。

主要发现

  • 小鼠胶质瘤细胞体外表达经典CD95但不表达CD95L,检测到编码可溶性异构体的非经典Cd95l转录变体。
  • 体内发现膜结合经典CD95L形式上調。
  • Cd95或Cd95l基因删除降低体外细胞生长,Cd95回补转染可恢复生长。
  • SMA-497模型中Cd95或Cd95l基因删除延长生存,涉及肿瘤内在和免疫机制。
  • GL-261模型不表达CD95,仅CD95L基因删除延长生存,涉及肿瘤内在机制。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Glioblastoma is the most common brain tumor in adults and is virtually incurable. Therefore, new therapeutic strategies are urgently needed. Over the last decade, multiple growth-promoting functions have been attributed to CD95, a prototypic death receptor well characterized as an apoptosis mediator upon CD95L engagement. Strategic targeting of non-apoptotic or apoptotic CD95 signaling may hold anti-glioblastoma potential. Due to its antithetic nature, understanding the constitutive role of CD95 signaling in glioblastoma is indispensable. METHODS: We abrogated constitutive Cd95 and Cd95l gene expression by CRISPR/Cas9 in murine glioma models and characterized the consequences of gene deletion in vitro and in vivo. RESULTS: Expression of canonical CD95 but not CD95L was identified in mouse glioma cells in vitro. Instead, a soluble isoform-encoding non-canonical Cd95l transcript variant was detected. In vivo, an upregulation of the membrane-bound canonical CD95L form was revealed. Cd95 or Cd95l gene deletion decreased cell growth in vitro. The growth-supporting role of constitutive CD95 signaling was validated by Cd95 re-transfection, which rescued growth. In vivo, Cd95 or Cd95l gene deletion prolonged survival involving tumor-intrinsic and immunological mechanisms in the SMA-497 model. In the GL-261 model, that expresses no CD95, only CD95L gene deletion prolonged survival, involving a tumor-intrinsic mechanism. CONCLUSION: Non-canonical CD95L/CD95 interactions are growth-promoting in murine glioma models, and glioma growth and immunosuppression may be simultaneously counteracted by Cd95l gene silencing.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Quijano-Rubio C, Silginer M, Weller M, et al. CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models. J Neurooncol. 2022. PMID: 36355258. doi:10.1007/s11060-022-04137-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。